In contrast, this association was missed by another observational study analyzing only anti-SSA prevalence, highlighting the importance of assessing separately anti-Ro60 and anti-Ro52 autoantibodies in the evaluation of pSS patients [30,31,32]. The gene discussed is CALR; the disease is peeling skin syndrome.